Table 1.
Comparison of expression of Gbp2b/Gbp1 or Gbp5 among mouse strains of CcS/Dem and OcB/Dem series in skin.
| CcS/Dem series |
OcB/Dem series |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Strain | BALB/c | STS | CcS-5 | CcS-16 | Strain | O20 | B10 | B10.O20 | OcB-9 |
| A. Gbp2b/Gbp1 uninfected | |||||||||
| BALB/c | O20 | ||||||||
| STS | 0.11 | B10 | 0.0047 | ||||||
| CcS-5 | 0.0012 | 0.0022 | B10.O20 | 1 | 0.0043 | ||||
| CcS-16 | 0.0012 | 0.0022 | 0.24 | OcB-9 | 0.035 | 0.0022 | 0.0043 | ||
| CcS-20 | 0.0012 | 0.0022 | 0.31 | 0.82 | OcB-43 | 0.23 | 0.0022 | 0.052 | 0.18 |
| B. Gbp2b/Gbp1 infected | |||||||||
| BALB/c | O20 | ||||||||
| STS | 0.54 | B10 | 0.043 | ||||||
| CcS-5 | 0.86 | 0.73 | B10.O20 | 0.0012 | 0.19 | ||||
| CcS-16 | 0.0076 | 0.0012 | 0.0022 | OcB-9 | 0.54 | 0.40 | 0.0047 | ||
| CcS-20 | 0.0048 | 0.0012 | 0.0022 | 0.59 | OcB-43 | 0.91 | 0.036 | 0.00012 | 0.30 |
| C. Gbp5 uninfected | |||||||||
| BALB/c | O20 | ||||||||
| STS | 0.37 | B10 | 0.73 | ||||||
| CcS-5 | 0.30 | 0.13 | B10.O20 | 0.20 | 0.25 | ||||
| CcS-16 | 0.051 | 0.041 | 0.82 | OcB-9 | 0.45 | 0.39 | 0.79 | ||
| CcS-20 | 0.0023 | 0.0022 | 0.31 | 0.093 | OcB-43 | 0.14 | 0.18 | 0.79 | 0.59 |
| D. Gbp5 infected | |||||||||
| BALB/c | O20 | ||||||||
| STS | 0.54 | B10 | 0.83 | ||||||
| CcS-5 | 0.18 | 0.37 | B10.O20 | 0.21 | 0.076 | ||||
| CcS-16 | 0.088 | 0.0012 | 0.0022 | OcB-9 | 0.088 | 0.15 | 0.000026 | ||
| CcS-20 | 0.036 | 0.0023 | 0.0022 | 0.49 | OcB-43 | 0.50 | 0.24 | 0.51 | 0.0012 |
A. Differences of Gbp2b/Gbp1 expression in uninfected skin; B. Differences of Gbp2b/Gbp1 expression in skin after 8 weeks of infection; C. Differences of Gbp5 expression in uninfected skin; D. Differences of Gbp5 expression in skin after 8 weeks of infection. Green: nominal (uncorrected) P value < 0.05; red: difference significant after correction for multiple testing at P < 0.05.